EGFR and non-small cell lung carcinoma: Additionally, other clinical parameters, such as biomarkers, including epidermal growth factor receptor, and the programmed death-1 (PD-1) ligand 1 (PD-L1) expression from histological and molecular analyses for NSCLC can be incorporated as input features for model modification, potentially improving the prediction capabilities with relevant parameters in other perspectives [58,59].